Yagudin, T,
Zhao, Y,
Gao, HY,
Zhang, Y,
Yang, Y,
Zhang, XF,
Ma, WB,
Daba, TM,
Ishmetov, V,
Kang, K,
Yang, BF,
Pan, ZW (2021) infarction in order to facilitate the development of novel
therapy. Inhibitor of apoptosis
Sangeet, Ghai,,
Ni, Tiffany T.,
Pavlovich, Christian P.,
Futterer, Jurgen J.,
Schade, George R.,
Sanchez-Salas, Rafael,
Cornud, Francois,
Eggener, Scott,
Feller, John F.,
George, Arvin K.,
Villers, Arnauld,
de la Rosette, Jean (2025) -related morbidities associated with conventional
therapies. Focal
therapy (FT) is emerging as a promising alternative
Fedorova, Yu Yu,
Sagitova, A.V.,
Mingazheva, E.T.,
Faishanova, R.R.,
Zagitov, I.R.,
Andreeva, E.A.,
Nurgalieva, A.Kh.,
Khusnutdinova, E.K.,
Darvish, M.,
Prokofyeva, D.S. (2024) researched – 89.91%, despite a good response to primary
therapy, had a relapse of the disease after 7 years